A Roadmap for Organoid Toxicology

How digital pathology and AI are helping validate complex in vitro models for preclinical safety testing

1

Complex in vitro models (CIVMs) like blood-brain barrier organoids enhance preclinical toxicity testing by simulating human tissue structures.
2

Standard histological techniques are essential for validating organoids, bridging bioengineering with established safety evaluation practices.
3

AI algorithms can automate single-cell toxicity assessments, improving efficiency and precision in evaluating organoid models.
4

Multidisciplinary collaboration among biologists, engineers, and pathologists is crucial for developing reliable organoid-based pathology workflows.
5

Future advancements in 3D modeling and automation will enhance the diagnostic utility of organoid-based pathology in personalized medicine.

1